The Search for New Psychedelics
Science Talk
Scientific American
4.2 • 644 Ratings
🗓️ 6 November 2023
⏱️ 11 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Understanding the human body is a team effort. That's where the Yachtel group comes in. |
| 0:05.8 | Researchers at Yachtolt have been delving into the secrets of probiotics for 90 years. |
| 0:11.0 | Yacold also partners with nature portfolio to advance gut microbiome science through the global grants for gut health, an investigator-led research program. |
| 0:19.6 | To learn more about Yachtolt, visit yawcult.co. |
| 0:22.7 | .jp. That's Y-A-K-U-L-T.C-O.jp. When it comes to a guide for your gut, count on Yacult. |
| 0:34.8 | When someone says psychedelics, what comes to mind? |
| 0:38.2 | Maybe magic mushrooms or LSD. |
| 0:40.7 | Or if you're a real aficionado, maybe you think of more obscure substances such as dimethylptamine, also called DMT, |
| 0:48.0 | or 4B325 dimethyoxyphenethlamine, also called 2CB. |
| 0:54.5 | Unless you're really deep in the psychedelic weeds, though, what probably doesn't come to mind are, say, |
| 1:00.1 | 4-hydroxy-in-methyl-in-isopropyl-triptamine, also called 4-H-O-M-I-PT, or 2-5-Demthioxy4-Nylophyllophenithlamine, also called 2C-T-7. |
| 1:16.8 | Yeah, these things are mouthfuls. |
| 1:19.6 | The latter two psychedelics are actually among hundreds of obscure consciousness-altering drugs. |
| 1:25.9 | Once that may be just a handful of people have ever tried, let alone studied. |
| 1:30.5 | Most are synthesized in labs, and new ones are being created all the time. |
| 1:34.6 | Some are made by underground chemists looking for the next big high, |
| 1:37.6 | but others are being created by bona fide scientists searching for better therapeutic agents. |
| 1:44.5 | For science quickly, I'm science journalist and author Rachel Neuer. |
| 1:48.7 | Today I'll be taking on a mind-bending journey, The Hunt for New Psychedelics. |
| 1:59.4 | I think the existing psychedelics are going to help a lot of people, but there are some people |
| 2:04.4 | that will not be helped by them or that will benefit even more from other medicines. |
| 2:11.2 | That's Matthew Baggett, a neuroscientist and co-founder and CEO of a startup called Tactogen. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

